title: Development of an ELISA for sensitive and specific detection of IgA autoantibodies against BP180 in pemphigoid diseases.
abstract: BACKGROUND
  Pemphigoids are rare diseases associated with IgG, IgE and IgA autoantibodies against collagen XVII/BP180. An entity of the pemphigoid group is the lamina lucida-type of linear IgA disease (IgA pemphigoid) characterized by IgA autoantibodies against BP180. While for the detection of IgG and IgE autoantibodies specific to collagen XVII several ELISA systems have been established, no quantitative immunoassay has been yet developed for IgA autoantibodies. Therefore, the aim of the present study was to develop an ELISA to detect IgA autoantibodies against collagen XVII in the sera of patients with pemphigoids.
  
  
  METHODS
  We expressed a soluble recombinant form of the collagen XVII ectodomain in mammalian cells. Reactivity of IgA autoantibodies from patients with IgA pemphigoid was assessed by immunofluorescence microscopy and immunoblot analysis. ELISA test conditions were determined by chessboard titration experiments. The sensitivity, specificity and the cut-off were determined by receiver-operating characteristics analysis.
  
  
  RESULTS
  The optimized assay was carried out using sera from patients with IgA pemphigoid (n = 30) and healthy donors (n=105). By receiver operating characteristics (ROC) analysis, an area under the curve of 0.993 was calculated, indicating an excellent discriminatory capacity. Thus, a sensitivity and specificity of 83.3% and 100%, respectively, was determined for a cut-off point of 0.48. As additional control groups, sera from patients with bullous pemphigoid (n=31) and dermatitis herpetiformis (n = 50), a disease associated with IgA autoantibodies against epidermal transglutaminase, were tested. In 26% of bullous pemphigoid patients, IgA autoantibodies recognized the ectodomain of collagen XVII. One of 50 (2%) of dermatitis herpetiformis patients sera slightly topped the cut-off value.
  
  
  CONCLUSIONS
  We developed the first ELISA for the specific and sensitive detection of serum IgA autoantibodies specific to collagen XVII in patients with pemphigoids. This immunoassay should prove a useful tool for clinical and translational research and should essentially improve the diagnosis and disease monitoring of patients with IgA pemphigoid. Moreover, our findings strongly suggest that IgA pemphigoid and IgG bullous pemphigoid represent two ends of the clinical spectrum of an immunological loss of tolerance against components of hemidesmosomes, which is mediated by both IgG and IgA autoantibodies.
authors: Department of Dermatology, University of Freiburg, Hauptstrasse 7, 79104, Freiburg, Germany.
authors: Kinga
authors: K
authors: Csorba
authors: Sabine
authors: S
authors: Schmidt
authors: Florina
authors: F
authors: Florea
authors: Norito
authors: N
authors: Ishii
authors: Takashi
authors: T
authors: Hashimoto
authors: Michael
authors: M
authors: Hertl
authors: Sarolta
authors: S
authors: Kárpáti
authors: Leena
authors: L
authors: Bruckner-Tuderman
authors: Wataru
authors: W
authors: Nishie
authors: Cassian
authors: C
authors: Sitaru
references: J Cell Mol Med. 2007 May-Jun;11(3):462-81
references: 17521373
references: J Invest Dermatol. 1994 Jun;102(6):878-81
references: 7516396
references: J Invest Dermatol. 1999 Jul;113(1):140-2
references: 10417635
references: J Invest Dermatol. 2002 Mar;118(3):485-92
references: 11874488
references: J Invest Dermatol. 2007 May;127(5):1167-74
references: 17235329
references: Br J Dermatol. 1979 Nov;101(5):535-42
references: 391262
references: J Invest Dermatol. 1998 Mar;110(3):207-10
references: 9506436
references: J Invest Dermatol. 1996 Apr;106(4):734-8
references: 8618013
references: Arch Dermatol. 1995 Jan;131(1):48-52
references: 7826096
references: Exp Dermatol. 2005 Dec;14(12):861-75
references: 16274453
references: Obstet Gynecol. 2004 Apr;103(4):757-63
references: 15051570
references: J Invest Dermatol. 1999 Dec;113(6):947-53
references: 10594735
references: J Dermatol Sci. 2006 Jan;41(1):21-30
references: 16364599
references: J Invest Dermatol. 2002 Apr;118(4):664-71
references: 11918714
references: J Invest Dermatol. 1997 Apr;108(4):423-9
references: 9077469
references: J Invest Dermatol. 2008 Nov;128(11):2736-2739
references: 18548115
references: J Am Acad Dermatol. 2009 Apr;60(4):676-8
references: 19293014
references: Semin Dermatol. 1988 Sep;7(3):225-32
references: 3153448
references: J Immunol Methods. 2009 Jul 31;346(1-2):18-25
references: 19422829
references: Arch Dermatol. 2008 Jan;144(1):41-8
references: 18209167
references: J Clin Invest. 1993 Nov;92(5):2480-8
references: 7693763
references: Clin Dermatol. 2001 Nov-Dec;19(6):719-27
references: 11705681
references: J Invest Dermatol. 2002 Nov;119(5):1065-73
references: 12445194
references: Curr Dir Autoimmun. 2008;10:141-66
references: 18460884
references: Arch Dermatol Res. 2007 Apr;299(1):1-8
references: 17277959
references: J Autoimmun. 2008 Dec;31(4):331-8
references: 18922680
references: J Invest Dermatol. 2010 Apr;130(4):1040-7
references: 19812601
references: Cell Mol Life Sci. 2010 Apr;67(8):1343-51
references: 20084423
references: J Clin Invest. 1990 Mar;85(3):812-20
references: 2107211
references: J Invest Dermatol. 1992 Sep;99(3):243-50
references: 1324962
references: J Biol Chem. 1998 Apr 17;273(16):9711-7
references: 9545306
references: Nat Med. 2007 Mar;13(3):378-83
references: 17322897
references: J Immunol. 2009 Sep 15;183(6):4088-93
references: 19717520
references: J Invest Dermatol. 1997 Nov;109(5):679-83
references: 9347799
references: J Invest Dermatol. 2007 Dec;127(12):2807-17
references: 17657247
references: Exp Dermatol. 2007 Sep;16(9):770-7
references: 17697150
references: J Dermatol Sci. 2002 Dec;30(3):224-32
references: 12443845
references: J Am Acad Dermatol. 2000 Apr;42(4):577-83
references: 10727301
references: J Invest Dermatol. 2007 Nov;127(11):2605-11
references: 17611576
references: J Invest Dermatol. 1999 Jul;113(1):133-6
references: 10417632
references: J Exp Med. 2002 Mar 18;195(6):747-57
references: 11901200
references: Clin Immunol. 2008 Sep;128(3):415-26
references: 18571472
references: Gastroenterology. 1998 Dec;115(6):1317-21
references: 9834256
references: Arch Dermatol. 2000 Feb;136(2):174-8
references: 10677092
references: J Invest Dermatol. 2009 Apr;129(4):822-4
references: 19322161
references: Br J Dermatol. 1999 Apr;140(4):750-2
references: 10233336
references: J Am Acad Dermatol. 1999 Dec;41(6):957-61
references: 10570380
references: Eur J Immunol. 2006 Apr;36(4):1039-48
references: 16552711
references: Exp Dermatol. 2010 Jul 1;19(7):648-53
references: 20500772
references: J Autoimmun. 2000 Nov;15(3):293-300
references: 11040070
references: Gastroenterology. 2005 Apr;128(4 Suppl 1):S87-91
references: 15825132
references: J Immunol. 2010 Oct 15;185(8):4938-47
references: 20861347
references: Gastroenterology. 2009 Dec;137(6):1912-33
references: 19766641
references: Prev Vet Med. 2000 May 30;45(1-2):23-41
references: 10802332
references: Arch Dermatol. 1976 Aug;112(8):1129-31
references: 782371
references: Arch Dermatol. 1977 Aug;113(8):1069-72
references: 329771
references: J Biol Chem. 1998 Oct 2;273(40):25937-43
references: 9748270
references: Arch Dermatol. 1995 Aug;131(8):957-8
references: 7669112